Tags

Type your tag names separated by a space and hit enter

Prospects and possible pitfalls of a preventive Polypill: confessions of a health promotion convert.
Eur J Clin Nutr. 2005 Aug; 59 Suppl 1:S4-8; discussion S9.EJ

Abstract

A proposal by Wald and Law (2003) for a single pill containing a statin, three half-dose antihypertensives, aspirin, and folic acid, met with a storm of controversy and seemed to have been relegated as much to the fanciful as to the accolades it might have deserved. The benefits such a Polypill could confer on people age 55+y were to reduce both cardiovascular and stroke events by 80% or more. Considering the daunting and, at best, slow process of changing the same risk factors through health promotion interventions on food policy, dietary and physical activity behaviors, and urban planning to make less prevalent the sedentary lifestyles developed over decades, the argument here is to view the Polypill as a harm reduction strategy that would complement health promotion, as Nicotine Replacement Therapy did for tobacco control, seat belts did for traffic injuries, and needle exchange programs did for secondary complications of injection drug use.

Authors+Show Affiliations

School of Medicine, University of California, San Francisco, CA 94127, USA. lwgreen@comcast.net

Pub Type(s)

Journal Article

Language

eng

PubMed ID

16052194

Citation

Green, L W.. "Prospects and Possible Pitfalls of a Preventive Polypill: Confessions of a Health Promotion Convert." European Journal of Clinical Nutrition, vol. 59 Suppl 1, 2005, pp. S4-8; discussion S9.
Green LW. Prospects and possible pitfalls of a preventive Polypill: confessions of a health promotion convert. Eur J Clin Nutr. 2005;59 Suppl 1:S4-8; discussion S9.
Green, L. W. (2005). Prospects and possible pitfalls of a preventive Polypill: confessions of a health promotion convert. European Journal of Clinical Nutrition, 59 Suppl 1, S4-8; discussion S9.
Green LW. Prospects and Possible Pitfalls of a Preventive Polypill: Confessions of a Health Promotion Convert. Eur J Clin Nutr. 2005;59 Suppl 1:S4-8; discussion S9. PubMed PMID: 16052194.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prospects and possible pitfalls of a preventive Polypill: confessions of a health promotion convert. A1 - Green,L W, PY - 2005/7/30/pubmed PY - 2005/10/29/medline PY - 2005/7/30/entrez SP - S4-8; discussion S9 JF - European journal of clinical nutrition JO - Eur J Clin Nutr VL - 59 Suppl 1 N2 - A proposal by Wald and Law (2003) for a single pill containing a statin, three half-dose antihypertensives, aspirin, and folic acid, met with a storm of controversy and seemed to have been relegated as much to the fanciful as to the accolades it might have deserved. The benefits such a Polypill could confer on people age 55+y were to reduce both cardiovascular and stroke events by 80% or more. Considering the daunting and, at best, slow process of changing the same risk factors through health promotion interventions on food policy, dietary and physical activity behaviors, and urban planning to make less prevalent the sedentary lifestyles developed over decades, the argument here is to view the Polypill as a harm reduction strategy that would complement health promotion, as Nicotine Replacement Therapy did for tobacco control, seat belts did for traffic injuries, and needle exchange programs did for secondary complications of injection drug use. SN - 0954-3007 UR - https://www.unboundmedicine.com/medline/citation/16052194/Prospects_and_possible_pitfalls_of_a_preventive_Polypill:_confessions_of_a_health_promotion_convert_ DB - PRIME DP - Unbound Medicine ER -